Cannabis stocks are not well-known for their stability or their income generation. I guess this makes sense since they do not have any earnings of their own to pay out. But if you are a risk-tolerant investor with a desire to gain some income from your cannabis stocks, this article will give you some ideas to take to the bank.

There are two primary ways to generate income from your cannabis investing. Both make use of options, although the strategies differ in how they operate. The first strategy makes use of put selling, selling another investor the right to sell you their shares at a specified price, or selling calls, which is the right for you to buy their shares at a specified price. In order to take on that risk, options sellers are rewarded with an option premium

Canada’s booming marijuana industry has been attracting considerable attention, especially since it became the first developed nation to legalize the recreational use of the drug. That event triggered a massive boom among marijuana companies with Canopy Growth (TSX:WEED)(NYSE:CGC) emerging as the industry leader.

The marijuana cultivator has grown from being the first publicly traded marijuana company in North America in early 2014 to now have a market cap of almost $20 billion and poised to enter the S&P/TSX 60 Index. This is a remarkable achievement and highlights why now is the time for investors to add Canopy to their portfolios.

High Tide Inc. ("High Tide" or the "Company") (CSE:HITI) (OTCQB:HTDEF) (FRA:2LY), an Alberta-based, retail-focused cannabis corporation enhanced by the manufacturing and wholesale distribution of smoking accessories and cannabis lifestyle products, announced that on Friday, April 12, 2019 the Alcohol and Gaming Commission of Ontario ("AGCO") approved and issued Retail Operator Licences (the "Licences") to High Tide's counterparties Steven Fry and Saturninus Partners (collectively, the "Winners") and also issued Retail Store Authorizations (the "Authorizations") to the Winners' respective stores Canna Cabana Hamilton ("Hamilton") and Canna Cabana Sudbury ("Sudbury").  The Winners are aiming to open their Canna Cabana-branded locations on or before April 20, 2019.

Big money is flowing into the legal marijuana industry, and both Wall Street and investors have taken notice. By the end of the next decade, depending on your preferred source, Wall Street investment banks foresee anywhere from $50 billion to $75 billion in annual sales, placing cannabis on par with the global soda industry.

There's no argument on Wall Street or among investors that the legal marijuana industry is on track to be one of the fastest-growing industries over the next five to 10 years. Depending on your preferred source, the global cannabis industry could top $31 billion in sales by 2022, and push onward to between $50 billion and $75 billion in total annual sales by the end of the next decade.

On the bright side, these revenue dollars have to go somewhere, which means there will be winners in the cannabis space. On the other hand, it's led to the almost cultlike buying of marijuana stocks based on name only, rather than underlying fundamentals.

Recently, I wrote about weed company Aphria’s ambitious $1 billion sales targetand the difficulty of hitting that goal. This time, I heard a similar tune from Canopy Growth (TSX:WEED)(NYSE:CGC). Being the largest publicly traded weed stock in the world, the goal of $1 billion net revenue is not ill-conceived.

Incredible growth opportunities in the stock market arguably come about just once or twice per generation. The legalization of marijuana in Canada this past October, and in more than three dozen countries around the world in recent years, just might be this generation's incredible growth story.

The global marijuana market is worth $150 billion, and industry watchers think widespread legalization could result in legal marijuana sales that top $200 billion worldwide in 15 years.

The potential to profit from pot is significant, but investors' optimism has caused valuations to rocket higher.

Although many marijuana stocks are trading near their 52-week highs, Aphria (NYSE:APHA), KushCo Holdings (NASDAQOTH:KSHB), and CannTrust Holdings (NYSE:CTST) have recently seen their share prices stumble. Should you buy these beaten-up pot stocks?

What's the best-performing big Canadian marijuana stock so far in 2019, with "big" defined as having a market cap of $3 billion or more? It's not Canopy Growth (NYSE:CGC). Nor is it Cronos Group(NASDAQ:CRON). Scratch Tilray (NASDAQ:TLRY) off the list, too. The biggest year-to-date winner in terms of stock performance is Aurora Cannabis (NYSE:ACB).

You won't find many marijuana stocks hotter than Organigram Holdings (NASDAQOTH:OGRMF) is right now. Actually, among Canadian marijuana stocks, you'll only find one. Organigram ranks as the No. 2 best-performing Canadian marijuana stock of the year so far. 

With the stock close to doubling year to date, it's no wonder more investors are starting to pay attention to Organigram. If you're in that group, here are five things you should know about Organigram before buying the stock.